Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection
Andrey V. Letarov, Vladislav V. Babenko, Eugene E. Kulikov
Biochemistry (Moscow) (2020) Vol. 86, Iss. 3, pp. 257-261
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19
Lize M. Grobbelaar, Chantelle Venter, Maré Vlok, et al.
Bioscience Reports (2021) Vol. 41, Iss. 8
Open Access | Times Cited: 156
Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs
Stephanie Seneff, Greg Nigh, Anthony M. Kyriakopoulos, et al.
Food and Chemical Toxicology (2022) Vol. 164, pp. 113008-113008
Open Access | Times Cited: 149
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte
Nunzia D’Onofrio, Lucia Scisciola, Celestino Sardu, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 93
The Role of Acidosis in the Pathogenesis of Severe Forms of COVID-19
Yury D. Nechipurenko, Denis Semyonov, I. A. Lavrinenko, et al.
Biology (2021) Vol. 10, Iss. 9, pp. 852-852
Open Access | Times Cited: 62
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
Mathieu Claireaux, Tom G. Caniels, Marlon de Gast, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 57
SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling
Scott B. Biering, Francielle Tramontini Gomes de Sousa, Laurentia V. Tjang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 46
Intranasal delivery of SARS-CoV-2 spike protein is sufficient to cause olfactory damage, inflammation and olfactory dysfunction in zebrafish
Aurora Kraus, Mar Huertas, Laura V. Ellis, et al.
Brain Behavior and Immunity (2022) Vol. 102, pp. 341-359
Open Access | Times Cited: 38
Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines
Paolo Bellavite, Alessandra Ferraresi, Ciro Isidoro
Biomedicines (2023) Vol. 11, Iss. 2, pp. 451-451
Open Access | Times Cited: 29
SARS-CoV-2 Spike Protein Accumulation in the Skull-Meninges-Brain Axis: Potential Implications for Long-Term Neurological Complications in post-COVID-19
Zhouyi Rong, Hongcheng Mai, Saketh Kapoor, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 24
mRNA: Vaccine or Gene Therapy? The Safety Regulatory Issues
Hélène Banoun
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10514-10514
Open Access | Times Cited: 24
SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
Nitin Kumar, Yu Zuo, Srilakshmi Yalavarthi, et al.
Viruses (2021) Vol. 13, Iss. 11, pp. 2209-2209
Open Access | Times Cited: 49
Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines
Mohammad Reza Zinatizadeh, Peyman Kheirandish Zarandi, Maryam Zinatizadeh, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112527-112527
Open Access | Times Cited: 42
Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination
Manuela De Michele, Joshua Kahan, Irene Berto, et al.
Circulation Research (2022) Vol. 130, Iss. 8, pp. 1187-1203
Open Access | Times Cited: 36
The SARS-CoV-2 S1 Spike Protein Promotes MAPK and NF-kB Activation in Human Lung Cells and Inflammatory Cytokine Production in Human Lung and Intestinal Epithelial Cells
Christopher B. Forsyth, Lijuan Zhang, Abhinav Bhushan, et al.
Microorganisms (2022) Vol. 10, Iss. 10, pp. 1996-1996
Open Access | Times Cited: 32
The emerging pandemic recent: SARS-CoV-2
Yoojin Cha, Wondong Jung, Min Jae Seo, et al.
Life Cycle (2023) Vol. 3
Open Access | Times Cited: 15
Persistence of spike protein at the skull-meninges-brain axis may contribute to the neurological sequelae of COVID-19
Zhouyi Rong, Hongcheng Mai, Gregor Ebert, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 12, pp. 2112-2130.e10
Open Access | Times Cited: 5
Blood-brain barrier function in response to SARS-CoV-2 and its spike protein
Łukasz Suprewicz, Krzysztof Fiedoruk, Agata Czarnowska, et al.
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 1, pp. 14-25
Open Access | Times Cited: 13
Prothrombotic Phenotype in COVID-19: Focus on Platelets
Cristina Barale, Elena Melchionda, Alessandro Morotti, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13638-13638
Open Access | Times Cited: 30
Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1
Theodore J. Cory, Russell Emmons, Johnathan R. Yarbro, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 27
A Functional Interaction Between Y674-R685 Region of the SARS-CoV-2 Spike Protein and the Human α7 Nicotinic Receptor
Juan Facundo Chrestia, A. Sofia F. Oliveira, Adrian J. Mulholland, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 10, pp. 6076-6090
Open Access | Times Cited: 21
Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents
Naomi S. Coombes, Kevin R. Bewley, Yann Le Duff, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 633-633
Open Access | Times Cited: 10
Effect of polyphenols against complications of COVID-19: current evidence and potential efficacy
Mahdi Vajdi, Arash Karimi, Shirin Hassanizadeh, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 2, pp. 307-327
Closed Access | Times Cited: 3
SARS-CoV-2 Invasion and Pathological Links to Prion Disease
Walter J. Lukiw, Vivian Jaber, Aileen I. Pogue, et al.
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1253-1253
Open Access | Times Cited: 16
Evaluation of the cross reactivity of neutralising antibody response in vaccinated human and convalescent hamster sera against SARS-CoV-2 variants up to and including JN.1 using an authentic virus neutralisation assay
Naomi S. Coombes, Kevin R. Bewley, Yann Le Duff, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19
Lize M. Grobbelaar, Chantelle Venter, Maré Vlok, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top